Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA: = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Elektronisch E-Book |
| Sprache: | German |
| Veröffentlicht: |
Berlin
2023
|
| Schlagworte: | |
| Online-Zugang: | kostenfrei kostenfrei |
| Beschreibung: | 1 Online-Ressource (71 Blätter) Diagramme |
| DOI: | 10.17169/refubium-39883 |
Internformat
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV049567113 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 006 | a m||| 00||| | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 240213s2023 |||| o||u| ||||||ger d | ||
| 024 | 7 | |a 10.17169/refubium-39883 |2 doi | |
| 024 | 7 | |a urn:nbn:de:kobv:188-refubium-40161-1 |2 urn | |
| 035 | |a (OCoLC)1422438127 | ||
| 035 | |a (DE-599)BVBBV049567113 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-578 | ||
| 084 | |a WJ 762 |2 nlm | ||
| 084 | |a 610 |2 FUB | ||
| 100 | 1 | |a Gaal, Sebastian |e Verfasser |0 (DE-588)1306319625 |4 aut | |
| 245 | 1 | 0 | |a Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA |b = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy |c vorgelegt von Sebastian Gaal |
| 246 | 1 | 1 | |a The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy |
| 264 | 1 | |a Berlin |c 2023 | |
| 300 | |a 1 Online-Ressource (71 Blätter) |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 502 | |b Dissertation |c Charité - Universitätsmedizin Berlin |d 2023 | ||
| 650 | 4 | |a DeRitis Ratio | |
| 650 | 4 | |a mCRPC | |
| 650 | 4 | |a metastatic castration-resistant prostate cancer | |
| 650 | 4 | |a radioligand therapy | |
| 650 | 4 | |a 177Lutetium-PSMA | |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |w (DE-604)BV049567114 |
| 856 | 4 | 0 | |u https://refubium.fu-berlin.de/handle/fub188/40161 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.17169/refubium-39883 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034912393 | ||
Datensatz im Suchindex
| _version_ | 1804186422398156800 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Gaal, Sebastian |
| author_GND | (DE-588)1306319625 |
| author_facet | Gaal, Sebastian |
| author_role | aut |
| author_sort | Gaal, Sebastian |
| author_variant | s g sg |
| building | Verbundindex |
| bvnumber | BV049567113 |
| collection | ebook |
| ctrlnum | (OCoLC)1422438127 (DE-599)BVBBV049567113 |
| doi_str_mv | 10.17169/refubium-39883 |
| format | Thesis Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01954nmm a2200445 c 4500</leader><controlfield tag="001">BV049567113</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="006">a m||| 00||| </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">240213s2023 |||| o||u| ||||||ger d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.17169/refubium-39883</subfield><subfield code="2">doi</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:kobv:188-refubium-40161-1</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1422438127</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049567113</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WJ 762</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">FUB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gaal, Sebastian</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1306319625</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA</subfield><subfield code="b">= The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy</subfield><subfield code="c">vorgelegt von Sebastian Gaal</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (71 Blätter)</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Charité - Universitätsmedizin Berlin</subfield><subfield code="d">2023</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DeRitis Ratio</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">mCRPC</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">metastatic castration-resistant prostate cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">radioligand therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">177Lutetium-PSMA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="w">(DE-604)BV049567114</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://refubium.fu-berlin.de/handle/fub188/40161</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.17169/refubium-39883</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034912393</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV049567113 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T23:29:43Z |
| indexdate | 2024-07-10T10:10:53Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034912393 |
| oclc_num | 1422438127 |
| open_access_boolean | 1 |
| owner | DE-578 |
| owner_facet | DE-578 |
| physical | 1 Online-Ressource (71 Blätter) Diagramme |
| psigel | ebook |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| record_format | marc |
| spelling | Gaal, Sebastian Verfasser (DE-588)1306319625 aut Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy vorgelegt von Sebastian Gaal The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy Berlin 2023 1 Online-Ressource (71 Blätter) Diagramme txt rdacontent c rdamedia cr rdacarrier Dissertation Charité - Universitätsmedizin Berlin 2023 DeRitis Ratio mCRPC metastatic castration-resistant prostate cancer radioligand therapy 177Lutetium-PSMA (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Druck-Ausgabe (DE-604)BV049567114 https://refubium.fu-berlin.de/handle/fub188/40161 Resolving-System kostenfrei Volltext https://doi.org/10.17169/refubium-39883 Resolving-System kostenfrei Volltext |
| spellingShingle | Gaal, Sebastian Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy DeRitis Ratio mCRPC metastatic castration-resistant prostate cancer radioligand therapy 177Lutetium-PSMA |
| subject_GND | (DE-588)4113937-9 |
| title | Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy |
| title_alt | The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy |
| title_auth | Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy |
| title_exact_search | Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy |
| title_exact_search_txtP | Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy |
| title_full | Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy vorgelegt von Sebastian Gaal |
| title_fullStr | Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy vorgelegt von Sebastian Gaal |
| title_full_unstemmed | Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy vorgelegt von Sebastian Gaal |
| title_short | Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA |
| title_sort | der deritis quotient als prognostischer faktor des metastasierten kastrationsresistenten prostatakarzinoms unter radioligandentherapie mit 177lutetium psma the deritis ratio as a prognostic factor for metastatic castration resistant prostate cancer treated with 177lutetium psma radioligand therapy |
| title_sub | = The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy |
| topic | DeRitis Ratio mCRPC metastatic castration-resistant prostate cancer radioligand therapy 177Lutetium-PSMA |
| topic_facet | DeRitis Ratio mCRPC metastatic castration-resistant prostate cancer radioligand therapy 177Lutetium-PSMA Hochschulschrift |
| url | https://refubium.fu-berlin.de/handle/fub188/40161 https://doi.org/10.17169/refubium-39883 |
| work_keys_str_mv | AT gaalsebastian derderitisquotientalsprognostischerfaktordesmetastasiertenkastrationsresistentenprostatakarzinomsunterradioligandentherapiemit177lutetiumpsmathederitisratioasaprognosticfactorformetastaticcastrationresistantprostatecancertreatedwith177lutetiumpsmaradiolig AT gaalsebastian thederitisratioasaprognosticfactorformetastaticcastrationresistantprostatecancertreatedwith177lutetiumpsmaradioligandtherapy |